Fresenius Can't Kill Nausea Drug IP Claims As Indefinite
Fresenius Kabi USA LLC lost its argument in Delaware federal court that some claims in several Heron Therapeutics nausea drug patents that it is accused of infringing are invalid as indefinite....To view the full article, register now.
Already a subscriber? Click here to view full article